FOR AFRICAN AND GLOBAL MARKETS
🎉 Our heartiest congratulations to our member Biovac for concluding a ground-breaking licensing and technology transfer agreement with International Vaccine Institute (IVI) to develop and manufacture oral cholera vaccine for African and global markets!
We are proud to see our members taking steps to advance towards achieving the goal of vaccine equity and expanding local manufacturing in the African continent.
For more information, click on the following press release:
